RPD
December 1, 2025

The US House passes the Give Kids a Chance Act to reauthorize the rare pediatric disease priority review voucher program

The US House passes the Give Kids a Chance Act to reauthorize the rare pediatric disease priority review voucher program to 2029. The Bill now goes onto the Senate for a vote before it can be passed onto the President and enacted into Law.

Track every
FDA Priority Review Voucher Program.

Stay updated
Thank you!
Oops! Something went wrong while submitting your email.

This webpage has been compiled from manually reviewing thousands of documents from the U.S. Securities and Exchange Commission (SEC), U.S. Food and Drug Administrations (FDA), Federal Register, press releases and financial records. The information on this page has been compiled from publicly available sources only and does not include any undisclosed PRV issuance's, transactions or redemptions.

Stay in the loop

News, analysis, and insights from the world of Priority Review Vouchers.

Thank you!
Oops! Something went wrong while submitting your email.